Compounds > erythrose
Page last updated: 2024-08-26

erythrose and Benign Neoplasms

erythrose has been researched along with Benign Neoplasms in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Angalene, JLA; Kumar, AM; Kumar, SS; Paulraj, P; Preethi, R; Raji, P; Roshini, SM; Samrot, AV; Stefi, SM1
Han Chang, TJ; Lau, CH; Leung, HM; Liu, LS; Lo, PK; Tam, DY; Tin, C; Wang, F1
Li, X; Li, Z; Yu, H1

Other Studies

3 other study(ies) available for erythrose and Benign Neoplasms

ArticleYear
Purification, characterization and utilization of polysaccharide of Araucaria heterophylla gum for the synthesis of curcumin loaded nanocarrier.
    International journal of biological macromolecules, 2019, Nov-01, Volume: 140

    Topics: Antineoplastic Agents; Antioxidants; Arabinose; Araucaria; Curcumin; Drug Delivery Systems; Galactose; Glucose; Glucosinolates; Humans; MCF-7 Cells; Neoplasms; Polysaccharides; Rhamnose; Spectroscopy, Fourier Transform Infrared; Tetroses

2019
Synthetic α-l-Threose Nucleic Acids Targeting BcL-2 Show Gene Silencing and in Vivo Antitumor Activity for Cancer Therapy.
    ACS applied materials & interfaces, 2019, Oct-23, Volume: 11, Issue:42

    Topics: Animals; Cell Proliferation; Gene Silencing; Humans; MCF-7 Cells; Mice; Mice, Nude; Microscopy, Confocal; Neoplasms; Oligonucleotides; Oligonucleotides, Antisense; Proto-Oncogene Proteins c-bcl-2; Tetroses; Transplantation, Heterologous

2019
Selection of threose nucleic acid aptamers to block PD-1/PD-L1 interaction for cancer immunotherapy.
    Chemical communications (Cambridge, England), 2020, Dec-04, Volume: 56, Issue:93

    Topics: Animals; Aptamers, Nucleotide; B7-H1 Antigen; Humans; Immunotherapy; Mice; Neoplasms; Programmed Cell Death 1 Receptor; Tetroses

2020